Skip to main content
. 2017 Jun 8;2017:2590676. doi: 10.1155/2017/2590676

Figure 1.

Figure 1

Apigenin alleviated ADR-induced myocardial injury. (a) Apigenin inhibited serum AST release. (b) Apigenin reduced serum LDH release. (c) Apigenin reduced serum CK contents. AST: aspartate amino transferase; LDH: lactate dehydrogenase; CK: creatine kinase-MB; control: control group; ADR: ADR model group (24 mg/kg); ADR + API (L): low-dose apigenin treatment group (125 mg/kg); ADR + API (H): high-dose apigenin treatment group (250 mg/kg); n = 10 per group. Values are presented as the mean ± SEM. ∗P < 0.05 compared with the control group; #P < 0.05 compared with the ADR model group.